14 Ocak 1953’te Kahramanmaraş’ta doğdu. 1970'te Kahramanmaraş Lisesi'ni, 1976 yılında Ankara Üniversitesi Tıp Fakültesi'ni birincilikle bitirdi. Aynı fakültede 1981'de İç Hastalıkları Uzmanı oldu. Aynı yıl, Strasbourg Louis Pasteur Üniversitesi’nde genetik manipülasyonlar üzerinde çalıştı. 1987'de Doçent, 1991’de İstanbul Üniversitesi Onkoloji Enstitüsü’nde Tıbbi Onkoloji Uzmanı, 1995’te Profesör oldu. ASCO ve sertifikalı ESMO üyesidir. Mart 2017’de kendi isteği ile, 29 yıl görev yaptığı İstanbul Üniversitesi Onkoloji Enstitüsü’nden ayrılarak İstinye Üniversitesi Tıp Fakültesi Bahçeşehir Liv Hospital’da göreve başladı. Tıbbi Onkoloji Derneği ve Onkoloji Grubu Derneği – Türk Onkoloji Grubu yönetim kurulu üyeliği yaptı. Evli ve 1 çocuklu olup çeşitli tıbbi kitap ve dergilerde Türkçe, İngilizce ve Fransızca toplam 121 adet yayını, ulusal ve uluslararası kongrelerde sunulmuş 109 adet bildirisi mevcuttur. Yayınlarından 41’i PubMed indeksli dergilerde yayımlanmıştır. Yayınlarına Şubat 2020’ye kadar toplam 3492 atıf yapılmış olup H-indeksi: 16, i10-indeksi: 22’dir (Kaynak: www.googlescholar.com). Katıldığı bazı uluslararası çalışmalar PETACC-1, CPT-CMA 202, Aventis V-306, V-307, CRYSTAL, RADIANT-2, CORRECT, RILOMET, REGARD ve MODUL olarak sıralanabilir. Diğer bir ilgi alanı teorik biyoloji, özellikle hücrelerarası iletişimdir. World Journal of Gastrointestinal Oncology (2018), Turkish Journal of Cancer (2003) ve Acta Oncologica (Turkish Edition) (2004) yayın kurulunda bulunan Prof. N. Faruk Aykan İngilizce ve Fransızca bilmektedir.
Araştırma Alanları
- Kolorektal kanser
- Mide kanseri
- Pankreas kanseri
- Nöroendokrin tömörleri
- İmmunoterapi
Çalışma Alanları
- Sağlık Bilimleri Temel Alanı
- Tıbbi Onkoloji (İç Hastalıkları)
- Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey, 2022
- Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients, 2019
- Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers, 2018
- Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study, 2018
- Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study, 2018
- Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: a family report, 2017
- CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA, 2017
- Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer, 2017
- CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIALBIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA, 2017
- Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers., 2017
- Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study, 2016
- Clinical significance of serum interleukin-17 levels in colorectal cancer patients, 2016
- Red meat and colorectal cancer, 2016
- Serum neural precursor cell expressed developmentally down regulated 9 NEDD9 level may have a prognostic role in patients with gastric cancer, 2015
- Red meat subtypes and colorectal cancer risk, 2015
- Clinical significance of serum claudin 1 and claudin 7 levels in patients with colorectal cancer, 2015
- Evaluation of Serum Interleukin 17 IL 17 Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma, 2015
- Serum nectin 2 levels are diagnostic and prognostic in patients with colorectal carcinoma, 2015
- Epidemiology of colorectal cancer in Turkey A cross sectional disease registry study A Turkish Oncology Group trial, 2015
- Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?, 2014
- Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients, 2014
- Effect of increased body mass index BMI on time to tumour progression TTP in unresectable metastatic colorectal cancer mCRC patients treated with bevacizumab based therapy, 2013
- Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection can we avoid radiotherapy in a subgroup of patients, 2013
- Prognostic significance of the metastatic lymph node ratio for survival in colon cancer, 2011
- A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma, 2011
- Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients, 2009
- The role of UFT in advanced gastric cancer, 2008
- Penile metastasis of cutaneous malignant melanoma a true hematogenous spread Case report and review of the literature, 2006
- Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer, 2004
- Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer., 2001
- Prognostic Factors in Pancreatic Carcinoma Serum LDH Levels Predict Survival in Metastatic Disease, 2001
- The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival, 2000
- A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma., 1998
- Body-mass Index and Health, ISBN: DOI: 10.5772/intechopen.78617, 2019
- Current Frontiers and Perspectives in Cell Biology, ISBN: 978-953-51-0544-2, 2019
- İleri evre mide kanserinde tedavi yaklaşımları, ISBN: 978-975-9118-71-6, 2018
- İleri evre mide kanserinde tedavi yaklaşımları, ISBN: 978-975-9118-71-6, 2018
- İLERİ EVRE MİDE KANSERİNDE TEDAVİ YAKLAŞIMLARI, ISBN: 978-975-9118-71-6, 2018
- Sindirim Sistemi Kanserleri, ISBN: , 1998
- Tıp Fakültesi mezuniyet birincilik ödülü, 1976
